ALEXIS ENTZ: Open Payments
NPI 1871277038 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $612 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $117 |
| GlaxoSmithKline, LLC. | 4 | $96 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 1 | $42 |
| Corium, LLC | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
Products named: VRAYLAR, SHINGRIX, INGREZZA, SPRAVATO, Azstarys, COBENFY, CAPLYTA, Jornay PM.
Industry payments across NY — which companies pay providers there.
